Search results
Inside Owen Boyle’s return to West Valley soccer after cancer and a foot amputation
Fairbanks Daily News-Miner· 7 days ago“I mean, soccer is definitely not something I can live without,” Boyle said by phone. Boyle broke...
People are tired of COVID and it’s impacting vaccine compliance — and more
WGN Chicago via Yahoo News· 3 days agoGreat Danes have the least cancer. Flat-coated retrievers had the highest mortality from cancer and...
Cedars-Sinai Guerin Children’s Expert Reelected to Leadership Position of Pediatric Oncology...
Newswise· 4 days agoLOS ANGELES (April 29, 2024) -- Cedars-Sinai Guerin Children’s pediatric oncologist Leo Mascarenhas, MD, MS, has been reelected as Children’s Oncology Group (COG) voting body chair for a second ...
King admits cancer diagnosis was a ‘bit of a shock’
Daily Telegraph· 3 days agoThe King and Queen were then introduced to patients and their loved ones. Lesley Woodbridge, 63, who was in for her second round of chemotherapy for a ...
Rakovina Therapeutics Inc. Announces 2023 Financial Results and Provides Corporate Update
Digital Journal· 6 days agoOn April 19, 2023, we presented new preclinical in vitro and in vivo data demonstrating the potential of our kt-3000 series against treatment-resistant Ewing sarcoma, a rare ...
Edison Oncology's Orotecan®: A Brighter Future For The Treatment of Recurrent Pediatric Cancers
International Business Times· 4 days agoDiagnosis of pediatric cancer is one of the worst news a family can receive. Having a young family member with cancer affects the entire family's dynamics and causes significant anxiety and ...
MD Anderson and Replay announce FDA clearance of IND application for first-in-class PRAME-targeted...
Newswise· 3 days agoMD Anderson and Replay today announced that the Food & Drug Administration (FDA) has issued a ‘safe to proceed’ for the Investigational New Drug (IND) appli
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 21 hours agoPlanegg/Martinsried, May 2, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, presented superior
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 3 days agoReplay and MD Anderson announce FDA clearance of IND application for first-in-class PRAME-targeted T-Cell Receptor Natural Killer (TCR-NK) cell therapy for hematological malignancies Phase 1/2 study in patients with relapsed/refractory AML
Study reveals cancer vulnerabilities in popular dog breeds
Phys.org· 4 days agoThe study, published in the Royal Society Open Science, set out to test a model of how cancer...